Private Label Tranexamic Acid Sunscreen Manufacturer Low MOQ

What percentage of tranexamic acid should be in a sunscreen formulation?

By Blake Mereby · Last reviewed October 4, 2026

Tranexamic acid is used in leave-on cosmetic formulations at concentrations typically ranging from 2% to 5% by weight. Within sunscreen formulations specifically, the most commercially common range is 2%–3%, with some premium or clinical-positioning products using up to 5%.

The reason concentrations don't go much higher in a sunscreen context is multifactorial. TXA is a water-soluble amino acid derivative, and at concentrations above 5% in an emulsion system, you begin to encounter texture and skin-feel issues — grittiness, tackiness, or reduced spreadability — that conflict with consumer expectations for a daily SPF product, which is already competing against the white-cast and heaviness associated with high-UV-filter loads.

Stability is the second constraint. Tranexamic acid is relatively stable at pH 5.0–6.5, which is compatible with most cosmetic emulsion systems. However, chemical UV filters like avobenzone are notoriously photolabile and are typically stabilized with photostabilizers (e.g., Tinosorb S, Bemotrizinol, or octocrylene — though octocrylene carries its own consumer perception challenges). The cosmetic chemist formulating your product needs to confirm that your TXA concentration doesn't interact with the stabilizer system or shift the formula pH into a range where UV filter degradation accelerates.

Mineral-only formulas (zinc oxide, titanium dioxide) are generally more compatible with TXA because the pH window is more forgiving and there is no photolabile filter chemistry to protect. Many low-MOQ manufacturers building stock TXA sunscreen bases default to a hybrid or mineral-only approach for exactly this reason — it simplifies stability.

From a consumer efficacy standpoint, published clinical literature on TXA for hyperpigmentation most commonly references topical concentrations of 2%–5% used twice daily over 8–12 weeks. If your brand positioning includes skin-brightening claims supported by clinical data, you should target the mid-to-upper end of that range (3%–5%) and ensure your claims language is carefully reviewed by a regulatory consultant — brightening claims can edge into drug territory if they reference melanin inhibition mechanisms.

Always request stability data from your manufacturer at your target TXA percentage in the specific formula base you are using. Bench-top data at 40°C/75% RH over 12 weeks (accelerated stability) is the minimum acceptable evidence before you commit to a production run. Real-time 12-month stability should follow for regulatory and quality assurance purposes.

Ingredients in this answer: Tranexamic Acid · Octocrylene · Avobenzone · Titanium Dioxide · Zinc Oxide

Read the full guide on Private Label Tranexamic Acid Sunscreen Manufacturer Low MOQ →

More about Private Label Tranexamic Acid Sunscreen Manufacturer Low MOQ

Tell us about your product

Tell us what you're making. Get an AI-drafted starting formula free, then have a vetted cosmetic chemist check it.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app